Affirm Holdings S&P 500 Inclusion: Stock Surges +2.1% on Index Hopes
Will the upcoming index rebalancing propel this fintech giant into the big leagues and spark a massive institutional buying frenzy?
Intel Chip Selloff -10.1%: Warning Sign for AI Bulls
Is Intel’s sharp drop just panic selling in semiconductors, or an early warning that the AI spending boom is losing steam?
Marvell Technology Forecast -8.5%: RBC Keeps $360 Target
Can Marvell Technology Forecast stay bullish after an 8.5% drop, or is Wall Street ignoring real execution risks?
Salesforce Upgrade +5% as Guggenheim Rejects AI Panic
Is this Salesforce Upgrade the start of a real rerating, or just a brief rebound after Wall Street priced in too much AI fear?
Applied Materials Short +11.6%: Rally Warning Grows
Is Michael Burry early again, or is Applied Materials flashing the kind of warning investors ignore at market peaks?
Eli Lilly Record at $1 Trillion as GLP-1 Boom Lifts LLY
Can Eli Lilly’s record run keep defying gravity as GLP-1 dominance and billion-dollar dealmaking reshape Big Pharma?
Moderna Strategy +13%: In Vivo CAR-T Surge Lifts MRNA
Can Moderna Strategy turn a vaccine story into a multi-platform biotech growth engine before the market prices it in?
Marvell Technology Forecast -9% as AI Momentum Meets Shock
Can Marvell Technology Forecast stay bullish after a 9% sell-off, or is Wall Street finally questioning the AI networking premium?
Marvell S&P 500 Inclusion -2.5% as AI Valuation Faces Test
Will Marvell S&P 500 Inclusion unlock lasting institutional demand, or is the stock already priced for perfection?
Accenture Earnings Drop 14.4% After Outlook Warning
Can Accenture Earnings still justify investor confidence after a sharp sell-off and a weaker revenue outlook?